Document is current
Any future updates will be listed below
-
Authors
Fan, Yanni
Delgado-Aros, Sílvia
Valdecantos, Wendell C.
Janak, Jud C.
Moore, Page C.
Crabtree, Margaux M.
Stidham, Ryan W. https://orcid.org/0000-0001-9638-2186
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
- License Information
-
More Information
Article History
Received: 13 December 2021
Accepted: 18 March 2022
First Online: 25 April 2022
Declarations
:
: This study design and conduct were the result of a collaborative effort between CorEvitas, LLC, and Boehringer Ingelheim. YF, SDA, and WCV are employed by Boehringer Ingelheim. PCM, JCJ, and MMC are employed by CorEvitas, LLC. RWS has received consultancy fees for AbbVie, Janssen, Merck, Takeda, Eli Lilly, Gilead, Exact Sciences, and CorEvitas, LLC, and has received investigator-initiated research support from AbbVie.
: The CorEvitas (formerly Corrona) LLC dataset is based on a large North American multicenter study adhering to a number of institutional review boards, with complex logistics. Patients did not provide consent to raw data sharing during the data collection for this purpose, and the CorEvitas data-sharing policies do not permit raw data sharing for this purpose. An aggregated limited dataset from the current approved analyses is available to qualified investigators with an approved protocol. Data requests may be sent to CorEvitas, LLC, represented by Dr. Jeffrey D. Greenberg MD, MPH, NYU School of Medicine, New York, NY, e-mail jgreenberg@corevitas.com.
